Intravitreal Bevacizumab for Choroidal Neovascular Membrane at the Edge of a Healed Choroidal Tuberculoma

ABSTRACT

The authors present a 36-year-old female with pulmonary tuberculosis who developed a choroidal tuberculoma in the left eye. The choroidal tuberculoma successfully resolved with visual gain following oral anti-tubercular and oral steroid therapy leaving behind a chorioretinal scar. One year after the completion of anti-tubercular treatment, she developed visual loss due to the development of a secondary choroidal neovascular membrane at the fovea. This was treated successfully with one intravitreal injection of bevacizumab in the left eye. The fovea remained free of fluid until the last follow-up 10 months after the intravitreal injection. Intravitreal bevacizumab may be an effective modality for treating secondary choroidal neovascular membranes that may form at the edge of a healed choroidal tuberculoma.

Keywords:

• Anti-vascular endothelial growth factor agents
• choroidal tubercle
• ocular tuberculosis
• subretinal fluid
• subretinal tubercular abscess

ACKNOWLEDGMENTS

We are grateful to Trina Sengupta Tripathy for her support and assistance in drafting the manuscript.

DECLARATION OF INTEREST

The authors report on conflicts of interest. The authors alone are responsible for the content and writing of the manuscript.